These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 20504136)

  • 1. Volume of prescription opioids used nonmedically in the United States.
    Katz NP; Birnbaum HG; Castor A
    J Pain Palliat Care Pharmacother; 2010 Jun; 24(2):141-4. PubMed ID: 20504136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. National drug control policy and prescription drug abuse: facts and fallacies.
    Manchikanti L
    Pain Physician; 2007 May; 10(3):399-424. PubMed ID: 17525776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of the nonmedical use of prescription opioid analgesics.
    Gilson AM; Kreis PG
    Pain Med; 2009 Jul; 10 Suppl 2():S89-100. PubMed ID: 19691688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Internet-based survey of nonmedical prescription opioid use in the United States.
    Katz N; Fernandez K; Chang A; Benoit C; Butler SF
    Clin J Pain; 2008; 24(6):528-35. PubMed ID: 18574362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wanted: a public health approach to prescription opioid abuse and diversion.
    Joranson DE; Gilson AM
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):632-4. PubMed ID: 16862603
    [No Abstract]   [Full Text] [Related]  

  • 6. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids.
    Manchikanti L; Singh A
    Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonmedical use of opioid analgesics among Ontario students.
    Brands B; Paglia-Boak A; Sproule BA; Leslie K; Adlaf EM
    Can Fam Physician; 2010 Mar; 56(3):256-62. PubMed ID: 20228312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do prescription monitoring programs impact state trends in opioid abuse/misuse?
    Reifler LM; Droz D; Bailey JE; Schnoll SH; Fant R; Dart RC; Bucher Bartelson B
    Pain Med; 2012 Mar; 13(3):434-42. PubMed ID: 22299725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foundations of opioid risk management.
    Katz NP; Adams EH; Benneyan JC; Birnbaum HG; Budman SH; Buzzeo RW; Carr DB; Cicero TJ; Gourlay D; Inciardi JA; Joranson DE; Kesslick J; Lande SD
    Clin J Pain; 2007 Feb; 23(2):103-18. PubMed ID: 17237659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nurses' Role in Preventing Prescription Opioid Diversion.
    Manworren RC; Gilson AM
    Am J Nurs; 2015 Aug; 115(8):34-40; quiz 41. PubMed ID: 26186473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National and international regulation of opioid drugs: purpose, structures, benefits and risks.
    Angarola RT
    J Pain Symptom Manage; 1990 Feb; 5(1 Suppl):S6-11. PubMed ID: 2324565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of prescription opioid abuse: the role of the dentist.
    Denisco RC; Kenna GA; O'Neil MG; Kulich RJ; Moore PA; Kane WT; Mehta NR; Hersh EV; Katz NP
    J Am Dent Assoc; 2011 Jul; 142(7):800-10. PubMed ID: 21719802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of a comprehensive risk-management program for prescription opioid analgesics: researched abuse, diversion and addiction-related surveillance (RADARS).
    Cicero TJ; Dart RC; Inciardi JA; Woody GE; Schnoll S; Muñoz A
    Pain Med; 2007 Mar; 8(2):157-70. PubMed ID: 17305687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France.
    Pauly V; Pradel V; Pourcel L; Nordmann S; Frauger E; Lapeyre-Mestre M; Micallef J; Thirion X
    Drug Alcohol Depend; 2012 Nov; 126(1-2):13-20. PubMed ID: 22475815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in opioid consumption in the Nordic countries 2002-2006.
    Hamunen K; Paakkari P; Kalso E
    Eur J Pain; 2009 Oct; 13(9):954-62. PubMed ID: 19091608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abuse-Deterrent Formulations and the Prescription Opioid Abuse Epidemic in the United States: Lessons Learned From OxyContin.
    Cicero TJ; Ellis MS
    JAMA Psychiatry; 2015 May; 72(5):424-30. PubMed ID: 25760692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002.
    Gilson AM; Ryan KM; Joranson DE; Dahl JL
    J Pain Symptom Manage; 2004 Aug; 28(2):176-88. PubMed ID: 15276196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement.
    Zacny J; Bigelow G; Compton P; Foley K; Iguchi M; Sannerud C
    Drug Alcohol Depend; 2003 Apr; 69(3):215-32. PubMed ID: 12633908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rx drug safety in TN: some successes, some challenges.
    Williams B
    Tenn Med; 2009 Apr; 102(4):21-3, 26-7. PubMed ID: 19385365
    [No Abstract]   [Full Text] [Related]  

  • 20. Assessment of the abuse of tapentadol immediate release: the first 24 months.
    Dart RC; Cicero TJ; Surratt HL; Rosenblum A; Bartelson BB; Adams EH
    J Opioid Manag; 2012; 8(6):395-402. PubMed ID: 23264317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.